US 12,186,468 B2
Compositions and methods for plasmapheresis
Dobri Kiprov, Seattle, WA (US)
Assigned to Circulate Health, Inc., Seattle, WA (US)
Filed by Circulate Health, Inc., Seattle, WA (US)
Filed on May 31, 2023, as Appl. No. 18/204,306.
Claims priority of provisional application 63/347,124, filed on May 31, 2022.
Prior Publication US 2024/0399044 A1, Dec. 5, 2024
Int. Cl. A61M 1/34 (2006.01); A61M 1/36 (2006.01)
CPC A61M 1/3496 (2013.01) [A61M 1/36 (2013.01)] 29 Claims
 
1. A method for treating a condition associated with aging in a human, comprising:
(a) performing plasmapheresis on the human at least two times per month for at least three months, wherein two of the at least two times per month are within the same week of the month;
(b) removing at least one plasma volume from the human during the plasmapheresis; and
(c) administering intravenous immunoglobulin to the human at each of the at least two times per month.